Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer - 11/05/19
Doi : 10.1016/j.det.2019.02.004
Kathleen M. Nemer, MD 1, M. Laurin Council, MD ⁎ 
Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA
∗Corresponding author. Center for Dermatologic and Cosmetic Surgery, 969 North Mason Road, Suite 200, Creve Coeur, MO 63141.Center for Dermatologic and Cosmetic Surgery969 North Mason Road, Suite 200Creve CoeurMO63141
Résumé |
Chemoprevention of nonmelanoma skin cancer should be considered in patients likely to develop numerous, invasive, or metastatic nonmelanoma skin cancers. This article reviews the various topical and systemic substances studied as chemopreventive agents.
Le texte complet de cet article est disponible en PDF.Keywords : Chemoprevention, Nonmelanoma skin cancer, Actinic keratosis, Basal cell carcinoma, Squamous cell carcinoma in situ, Squamous cell carcinoma, Immunosuppression, Organ transplant recipient
Plan
| Disclosure Statement: The authors have no commercial/financial conflicts of interest or funding sources. |
© 2019
Elsevier Inc. Tous droits réservés.
Vol 37 - N° 3
P. 287-295 - juillet 2019 Retour au numéro
Article précédent
- Management of Skin Cancer in the Elderly
- Michael Renzi, Josh Schimmel, Ashley Decker, Naomi Lawrence
- Medications Associated with Increased Risk of Keratinocyte Carcinoma
- Lauren D. Crow, Katherine A. Kaizer-Salk, Hailey M. Juszczak, Sarah T. Arron
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?